Clinical Outcomes and Prognostic Factors in Complex, High-Risk Indicated Procedure (CHIP) and High-Bleeding-Risk (HBR) Patients Undergoing Percutaneous Coronary Intervention with Sirolimus-Eluting Stent Implantation: 4-Year Results

Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence

(2023) Francesco Condello et al.   Journal of Clinical Medicine

Comparison of Long-Term Clinical Outcomes of Elective Percutaneous Coronary Intervention Between Complex and High-risk Intervention in Indicated Patients (CHIP) versus Non-CHIP

(2023) Yudai Fujimoto et al.   AMERICAN JOURNAL OF CARDIOLOGY

Machine Learning Identifies New Predictors on Restenosis Risk after Coronary Artery Stenting in 10,004 Patients with Surveillance Angiography

(2023) Ulrich Güldener et al.   Journal of Clinical Medicine

Early vs. Late Readmission following Percutaneous Coronary Intervention: Predictors and Impact on Long-Term Outcomes

(2023) David Eccleston et al.   Journal of Clinical Medicine

Comparison of Orbital Atherectomy and Rotational Atherectomy in Calcified Left Main Disease: Short-Term Outcomes

(2023) Piotr Rola et al.   Journal of Clinical Medicine

Impact of in-Hospital Left Ventricular Ejection Fraction Recovery on Long-Term Outcomes in Patients Who Underwent Impella Support for HR PCI or Cardiogenic Shock: A Sub-Analysis from the IMP-IT Registry

(2023) Mario Iannaccone et al.   Journal of Personalized Medicine

Outcomes with P2Y12 inhibitor monotherapy after PCI according to bleeding risk: A Bayesian meta-analysis

(2023) Eva C.I. Woelders et al.   Cardiovascular Revascularization Medicine

Complex and high-risk intervention in indicated patients (CHIP) in contemporary clinical practice

(2023) Yudai Fujimoto et al.   Cardiovascular Intervention and Therapeutics

Temporal Trends of Major Bleeding and Its Prediction by the Academic Research Consortium-High Bleeding Risk Criteria in Acute Myocardial Infarction

(2022) Sungwook Byun et al.   Journal of Clinical Medicine

Safety and Feasibility of Distal Radial Balloon Aortic Valvuloplasty

(2022) Alexandru Achim et al.   JACC-Cardiovascular Interventions

Switching From Proximal to Distal Radial Artery Access for Coronary Chronic Total Occlusion Recanalization

(2022) Alexandru Achim et al.   Frontiers in Cardiovascular Medicine

Race-Ethnic Differences of ST -Elevation Myocardial Infarction: Findings from a New York Health System Registry

(2022) Christopher S. G. Murray et al.   ETHNICITY & DISEASE

Predictors and Prognostic Impact of Left Ventricular Ejection Fraction Recovery after Impella-Supported Percutaneous Coronary Interventions in Acute Myocardial Infarction

(2022) Federico Marin et al.   Journal of Personalized Medicine

Global research trends in in-stent neoatherosclerosis: A CiteSpace-based visual analysis

(2022) Heng Wang et al.   Frontiers in Cardiovascular Medicine

Comparison of Outcomes of Elective Percutaneous Coronary Intervention between Complex and High-Risk Intervention in Indicated Patients (CHIP) versus Non-CHIP

(2022) Yudai Fujimoto et al.   Journal of Atherosclerosis and Thrombosis

Long-Term Outcomes Following Drug-Eluting Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis (DEB-Dragon-Registry)

(2021) Wojciech Wańha et al.   Circulation-Cardiovascular Interventions

Comparison of Performance between ARC-HBR Criteria and PRECISE-DAPT Score in Patients Undergoing Percutaneous Coronary Intervention

(2021) Sun Young Choi et al.   Journal of Clinical Medicine

Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

(2019) Philip Urban et al.   EUROPEAN HEART JOURNAL

Clinical expert consensus document on the use of percutaneous left ventricular assist support devices during complex high-risk indicated PCI

(2019) Alaide Chieffo et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels

(2019) Rosaly A. Buiten et al.   JAMA Cardiology

Restenosis of Drug-Eluting Stents

(2019) Evan Shlofmitz et al.   Circulation-Cardiovascular Interventions

Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model

(2016) Piotr P. Buszman et al.   Cardiology Journal

Wykorzystanie stentów bioresorbowalnych Absorb BVS® u pacjentów ze stabilną chorobą wieńcową: ocena skuteczności i bezpieczeństwa leczenia hybrydowego stentów bioresorbowalnych i stentów uwalniających lek

(2016) Robert J. Gil et al.   Kardiologia Polska

Long-Term Outcome of Sirolimus-Eluting and Zotarolimus-Eluting Coronary Stent Implantation in Patients With and Without Diabetes Mellitus (A Danish Organization for Randomized Trials on Clinical Outcome III Substudy)

(2015) Kevin K.W. Olesen et al.   AMERICAN JOURNAL OF CARDIOLOGY

Novel sirolimus-eluting stent Prolim® with a biodegradable polymer in the all-comers population: one year clinical results with quantitative coronary angiography and optical coherence tomography analysis

(2015) Jacek Bil et al.   BMC Cardiovascular Disorders

A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the diabedES IV randomized angiography trial)

(2015) Michael Maeng et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

High-Risk Percutaneous Coronary Interventions in Modern Day Clinical Practice

(2015) Theodore A. Bass   Circulation-Cardiovascular Interventions

Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial

(2014) W. Wijns et al.   EUROPEAN HEART JOURNAL

Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trials

(2013) Antoinette de Waha et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II

(2013) Vasim Farooq et al.   LANCET

Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials

(2012) G. G. Stefanini et al.   EUROPEAN HEART JOURNAL

Prevalence and prognosis of coronary stent gap detected by multi-detector CT: a follow-up study

(2012) Xinghua Zhang et al.   EUROPEAN RADIOLOGY

Sirolimus-eluting stents reduce long-term mortality compared with bare metal stents in ST-segment elevation myocardial infarction: A meta-analysis of randomized controlled trials

(2012) Ryota Sakurai et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY